Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_assertion description "[For example, systemic delivery of recombinant ES to rat insulin promoter 1 (Rip1)T-antigen 2 (Tag2)-transgenic mice, a mouse model of pancreatic beta-cell carcinogenesis, has repressed tumor angiogenesis efficiently and with it, tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_assertion evidence source_evidence_literature NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_assertion SIO_000772 16793908 NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_assertion wasDerivedFrom befree-20140225 NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_assertion wasGeneratedBy ECO_0000203 NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP772112.RAFyntHicaRy5_7uiMlN2oZg-p8abL6dyqk4u6y0H3fh8130_provenance.